%0 Journal Article
%T TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study
%A Arthur J. Mayorga
%A Christopher M. Flores
%A Gary Romano
%A John A. Moyer
%A Kevin Shalayda
%A Michael Brandt
%A Prasarn Manitpisitkul
%A Velga Kenigs
%J Archive of "Pain Reports".
%D 2016
%R 10.1097/PR9.0000000000000576
%K Capsaicin-induced flare
%K JNJ-39439335
%K Heat pain detection
%K Mavatrep
%K Pharmacokinetics
%K Pharmacodynamics
%K TRPV1 receptor antagonist
%K Single ascending dose
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741288/